Glucocorticoids aggravate hyperoxia-induced lung injury through decreased nuclear factor-κB activity

被引:19
作者
Barazzone-Argiroffo, C
Pagano, A
Juge, C
Métrailler, I
Rochat, A
Vesin, C
Donati, Y
机构
[1] Univ Geneva, Sch Med, Dept Pediat, CH-1211 Geneva 4, Switzerland
[2] Univ Geneva, Sch Med, Dept Pathol, CH-1211 Geneva 4, Switzerland
[3] Univ Geneva, Sch Med, Dept Internal Med, Div Endocrinol, CH-1211 Geneva 4, Switzerland
关键词
mice; oxygen; apoptosis; steroid;
D O I
10.1152/ajplung.00239.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
We previously reported that exposure of mice to hyperoxia is characterized by extensive lung cell necrosis and apoptosis, mild inflammatory response, and elevated circulating levels of corticosterone. Administration of hydroxycortisone acetate during hyperoxia aggravated lung injury. Using adrenalectomized (ADX) and sham-operated (sham) mice, we studied the role of the glucocorticoids in hyperoxia-induced lung injury. Lung damage was attenuated in ADX mice as measured by lung weight and protein and cell content in bronchoalveolar lavage and as seen by light microscopy. Mortality was delayed by 10 h. Nuclear factor-kappaB (NF-kappaB) activity was significantly decreased in lungs of sham mice exposed to hyperoxia but was preserved in ADX mice. There was a correlation between NF-kappaB activity in ADX mice and decreased levels of IkappaBalpha. In contrast, activator protein-1 activity increased similarly in both groups of mice. Levels of interleukin-6 (IL-6), a transcriptional target of NF-kappaB, were higher in bronchoalveolar lavage and serum of ADX than sham mice. However, the protective effect of ADX was not mediated by IL-6, because administration of recombinant human IL-6 to sham mice did not prevent lung damage. These results demonstrate that the adrenal response aggravates alveolar injury and is likely to be mediated by the decrease of NF-kappaB function involved in cell survival.
引用
收藏
页码:L197 / L204
页数:8
相关论文
共 45 条
[1]   Hyperoxia synergistically increases TNF-α-induced interleukin-8 gene expression in A549 cells [J].
Allen, GL ;
Menendez, IY ;
Ryan, MA ;
Mazor, RL ;
Wispé, JR ;
Fiedler, MA ;
Wong, HR .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 278 (02) :L253-L260
[2]   CD40-CD40 ligand disruption does not prevent hyperoxia-induced injury [J].
Argiroffo, CB ;
Donati, YR ;
Boccard, J ;
Rochat, AF ;
Vesin, C ;
Kan, CD ;
Piguet, PF .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (01) :67-71
[3]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[4]   Changes in the pathogenesis and prevention of chronic lung disease of prematurity [J].
Bancalari, E .
AMERICAN JOURNAL OF PERINATOLOGY, 2001, 18 (01) :1-9
[5]   Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury [J].
Barazzone, C ;
Belin, D ;
Piguet, PF ;
Vassalli, JD ;
Sappino, AP .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) :2666-2673
[6]   Hyperoxia induces platelet activation and lung sequestration: An event dependent on tumor necrosis factor-alpha and CD11a [J].
Barazzone, C ;
TacchiniCottier, F ;
Vesin, C ;
Rochat, AF ;
Piguet, PF .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1996, 15 (01) :107-114
[7]   Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice [J].
Barazzone, C ;
Donati, YR ;
Rochat, AF ;
Vesin, C ;
Kan, CD ;
Pache, JC ;
Piguet, PF .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (05) :1479-1487
[8]   Hyperoxia increases leptin production: a mechanism mediated through endogenous elevation of corticosterone [J].
Barazzone-Argiroffo, C ;
Muzzin, P ;
Donati, YR ;
Kan, CD ;
Aubert, ML ;
Piguet, PF .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 281 (05) :L1150-L1156
[9]   Reversal of late septic shock with supraphysiologic doses of hydrocortisone [J].
Bollaert, PE ;
Charpentier, C ;
Levy, B ;
Debouverie, M ;
Audibert, G ;
Larcan, A .
CRITICAL CARE MEDICINE, 1998, 26 (04) :645-650
[10]  
Burri PH, 1997, LUNG GROWTH DEV, P1